Hyperlipidemia
Episodes 1-16 of 36
Ulrich Laufs, MD, PhD
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program credits
Julia Brandts, MD
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program creditsProf. Kausik Ray
Pasquale Perrone-Filardi, MD, PhD
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesKausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
John Kastelein, MD, PhD
Prof. Alberto Zambon MD, PhD, FAHA
Kausik Ray, MBChB, MD, MPhil
Azfar Zaman, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
- MinuteCE®
Understanding the role of triglycerides in the assessment of residual risk
0.50 program creditsProf. Alberto Zambon MD, PhD, FAHA
Daniel Gaudet, MD, PhD
Christie M. Ballantyne, MD, FACP, FACC
Erik Stroes, MD, PhD
P. Gabriel Steg, MD
Pam R. Taub, MD, FACC, FASPC
- Prev
- Next